SCHEMBL330797

SCHEMBL330797

CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC.Cc1ccc(S(=O)(=O)[O-])cc1

nearest known ligand 0.57

Known targets — ChEMBL curated mechanism

CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.57
CYP2C9 P11712 3/20 0.57
KCNH2 Q12809 2/20 0.57
CYP2D6 P10635 2/20 0.57
CYP2C19 P33261 2/20 0.57
TSHR P16473 2/20 0.57
HTT P42858 1/20 0.57
HIF1A Q16665 1/20 0.57
MCHR1 Q99705 1/20 0.48
NR1I2 O75469 1/20 0.47
CYP3A4 P08684 2/20 0.45
MAPK1 P28482 1/20 0.45
THPO P40225 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 4/20 0.41
DNM1 Q05193 6/20 0.39
ALB P02768 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL331299 1.00 LMNA (0.57) LMNACYP2C9KCNH2CYP2D6CYP2C19
SCHEMBL31222502 1.00 LMNA (0.57) LMNACYP2C9KCNH2CYP2D6CYP2C19
SCHEMBL330997 1.00 LMNA (0.57) LMNACYP2C9KCNH2CYP2D6CYP2C19
SCHEMBL331650 1.00 LMNA (0.57) LMNACYP2C9KCNH2CYP2D6CYP2C19
Tributylmethylammonium SCHEMBL3189539 0.93 LMNA (0.50) LMNACYP2C9KCNH2CYP2D6CYP2C19
SCHEMBL9189137 0.93 LMNA (0.52) LMNACYP2C9KCNH2CYP2D6CYP2C19
SCHEMBL27477177 0.93 LMNA (0.52) LMNACYP2C9KCNH2CYP2D6CYP2C19
SCHEMBL11333814 0.92 LMNA (0.57) LMNACYP2C9KCNH2CYP2D6CYP2C19
SCHEMBL8723514 0.92 LMNA (0.59) LMNACYP2C9KCNH2CYP2D6CYP2C19
Cetrimonium SCHEMBL121980 0.92 LMNA (0.59) LMNACYP2C9KCNH2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240132714-A1 EPOXY RESIN COMPOSITION, SEMICONDUCTOR DEVICE, AND METHOD OF PRODUCING SEMICONDUCTOR DEVICE NAMICS CORPORATION (JP) 2024-04-25 US claimed
CN-116917409-A Epoxy resin composition, semiconductor device, and method for manufacturing semiconductor device 纳美仕有限公司 2023-10-20 CN claimed
WO-2023276814-A1 EPOXY RESIN COMPOSITION, SEMICONDUCTOR DEVICE, AND METHOD FOR PRODUCING SEMICONDUCTOR DEVICE ナミックス株式会社 2023-01-05 WO claimed
EP-2116558-B1 POLYMERIZABLE COMPOSITION CONTAINING A CATALYST, OPTICAL MATERIAL OBTAINED FROM THE COMPOSITION, AND METHOD FOR PRODUCING THE OPTICAL MATERIAL MITSUI CHEMICALS INC (JP) 2017-01-18 EP claimed
EP-1812382-B1 METHOD FOR PRODUCING POLYISOCYANATES BASF SE (DE) 2013-01-23 EP claimed
US-20100016517-A1 POLYMERIZATION CATALYST FOR POLYTHIOURETHANE-BASED OPTICAL MATERIAL, POLYMERIZABLE COMPOSITION CONTAINING THE CATALYST, OPTICAL MATERIAL OBTAINED FROM THE COMPOSITION, AND METHOD FOR PREPARING THE OPTICAL MATERIAL MITSUI CHEMICALS, INC (JP) 2010-01-21 US claimed
EP-2116558-A1 POLYMERIZATION CATALYST FOR POLYTHIOURETHANE OPTICAL MATERIAL, POLYMERIZABLE COMPOSITION CONTAINING THE CATALYST, OPTICAL MATERIAL OBTAINED FROM THE COMPOSITION, AND METHOD FOR PRODUCING THE OPTICAL MATERIAL Mitsui Chemicals, Inc. (JP) 2009-11-11 EP claimed
US-20090112017-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESSELLSCHAFT (DE) 2009-04-30 US claimed
EP-1812382-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESELLSCHAFT (DE) 2007-08-01 EP claimed
WO-2006048171-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESELLSCHAFT (DE) 2006-05-11 WO claimed
CN-120010045-A Optical laminate and method for producing same 住友化学株式会社 2025-05-16 CN disclosed
CN-119828277-A Laminate and composition for forming vertical alignment liquid crystal cured film 住友化学株式会社 2025-04-15 CN disclosed
WO-2025070759-A1 LIGHT ABSORPTION ANISOTROPIC FILM, OPTICAL FILM, AND IMAGE DISPLAY DEVICE 富士フイルム株式会社 2025-04-03 WO disclosed
CN-114051586-B Strip film 住友化学株式会社 2025-02-07 CN disclosed
CN-113906322-B Composition for forming liquid crystal cured film and use thereof 住友化学株式会社 2024-11-29 CN disclosed
EP-1789160-A1 METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE BASF AKTIENGESELLSCHAFT (DE) 2007-05-30 EP disclosed
WO-2006048171-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESELLSCHAFT (DE) 2006-05-11 WO disclosed
WO-2006029788-A1 METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE BASF AKTIENGESELLSCHAFT (DE) 2006-03-23 WO disclosed
US-6849676-B1 Antistatic polyurethane elastic fiber and material for producing the same MATSUMOTO YUSHI-SEIYAKU CO., LTD. (JP) 2005-02-01 US disclosed
US-5800624-A LIPOPHILIC POLYMER, HYDROPHOBIC PLASTICIZER, QUATERNARY AMMONIUM OR PHOSPHONIUM CARRIER UNIVERSITY OF NOTRE DAME (US) 1998-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090112017-A1 METHOD FOR PRODUCING POLYISOCYANATES PGLS, INMT, PNMT LMNA 1276/4885CYP2C9 565/4885KCNH2 862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.